This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom
The drug XIMLUCI contains one active pharmaceutical ingredient (API):
|
1
Ranibizumab
UNII ZL1R02VT79 - RANIBIZUMAB
|
|
Ranibizumab is a humanised recombinant monoclonal antibody fragment targeted against human vascular endothelial growth factor A (VEGF-A). It binds with high affinity to the VEGF-A isoforms, thereby preventing binding of VEGF-A to its receptors VEGFR-1 and VEGFR-2. Binding of VEGF-A to its receptors leads to endothelial cell proliferation and neovascularisation, as well as vascular leakage, all of which are thought to contribute to the progression of the neovascular form of age-related macular degeneration, pathologic myopia and CNV or to visual impairment caused by either diabetic macular oedema or macular oedema secondary to RVO in adults and retinopathy of prematurity in preterm infants. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| XIMLUCI Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01LA04 | Ranibizumab | S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1893898 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1221691001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 106747 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 67026689 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 050443011, 050443023 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1095941, 1095942 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W69269001, W69269002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
